Skip to main content

TUDOR INVESTMENT CORP ET AL

Position in NTLA — Intellia Therapeutics, Inc.

CIK 923093 STAMFORD, CT

Position in NTLA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,978,083
+$834,245 QoQ
Shares Held
116,908
+31.0% QoQ
Ownership
0.083%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#86
of 330 holders
Holding Since
Jun 2021
15 quarters on record
Voting authority Sole 50% Shared 50% None 0%

Common Shares in NTLA Over Time

Shares Held

Position Value (USD)

Derivatives in NTLA

reported options exposure · as of Jun 30, 2026
CallValue
$0
CallShares
0
PutValue
$216,576
PutShares
12,800

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

TUDOR INVESTMENT CORP ET AL holds $414,135,114 across 107 Biotechnology names. NTLA ranks #38 (0.5% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in NTLA

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,978,083 116,908
2026-06-30 $216,576 12,800
2026-03-31 $1,143,838 89,223
2025-12-31 $1,699,793 189,076
2025-12-31 $134,850 15,000
2025-06-30 $1,078,362 114,964
2025-03-31 $485,449 68,277
2024-12-31 $167,904 14,400
2024-09-30 $509,701 24,803
2024-06-30 $1,382,703 61,783
2024-03-31 $1,306,037 47,475
2023-09-30 $241,513 7,638
2022-12-31 $1,566,630 44,902
2022-09-30 $1,739,516 31,085
2022-03-31 $1,400,568 19,273
2021-09-30 $1,624,422 12,109
2021-06-30 $1,207,039 7,455